BioMed Central Lin HT et al
Compared to anti-inflammatory peptides such as LL-37 or cathelicidins, BPC-157 does not display direct antimicrobial activity but modulates the immune-vascular axis in a more refined manner
Anecdotally, BPC-157 is said to produce effects within days to weeks, but no peer-reviewed human studies confirm the onset or speed of action
Where BPC-157 and TB-500 act primarily through actin/cytoskeletal and growth-factor pathways, GHK-Cu's mechanism is dominated by transcriptional reprogramming via copper-dependent gene regulation, making it a complementary research tool when investigators wish to dissect transcription-driven from structural-protein-driven repair phenotypes
It points to a specific co-formulated absorption enhancer, sodium N-8-2-hydroxybenzoyl-amino-caprylic acid, that enables the peptide to cross the intestinal wall
For semaglutide, that minimum is 48 hours